Across TCGA cell cohorts, KRTAP12-3 RNA expression is significantly associated with the mutation status of many other genes, with 440 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible KRTAP12-3-associated genes across cancer lineages are CILP2, SLC9C2, and OVCH1. Each is linked with KRTAP12-3 in more than 1 cancer types. Because this analysis shows association rather than direction, both KRTAP12-3-to-partner and partner-to-KRTAP12-3 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (KRTAP12-3→partner) and Y-score (partner→KRTAP12-3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	CILP2 →	+3.316	+0.047	.003	<.001	3	2
BLOOD_Leukemia	SLC9C2 →	+4.539	+0.058	.007	<.001	3	2
BLOOD_Leukemia	OVCH1 →	+5.539	+0.124	.003	<.001	3	2
BLOOD_Leukemia	AHNAK →	+2.539	+0.030	.001	<.001	3	2
BLOOD_Leukemia	PDE11A →	+4.539	+0.087	.007	<.001	3	2
BLOOD_Myeloma	SCN9A →	+4.807	+0.116	.006	<.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 440 associations by consensus.

Exploration

KRTAP12-3 survival (RNA) · tumor vs normal (RNA) · all KRTAP12-3 data types